Carmustine (BCNU)


Indications


Pharmacology


Administration


Adverse Effects

Pulmonary Adverse Effects

Interstitial Pulmonary Fibrosis (see Interstitial Lung Disease-Etiology, [[Interstitial Lung Disease-Etiology]])

Upper Lobe Fibro-Bullous Changes (see Cystic-Cavitary Lung Lesions, [[Cystic-Cavitary Lung Lesions]])

Acute Lung Injury-ARDS (see Acute Lung Injury-ARDS, [[Acute Lung Injury-ARDS]])

Pneumothorax (see Pneumothorax, [[Pneumothorax]])

Pulmonary Veno-Occlusive Disease (see Pulmonary Veno-Occlusive Disease, [[Pulmonary Veno-Occlusive Disease]])

Other Adverse Effects


References